Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gynecologic Surgical Procedures | 5 | 2024 | 66 | 1.720 |
Why?
|
| Vagina | 2 | 2024 | 201 | 0.930 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2024 | 75 | 0.750 |
Why?
|
| Robotic Surgical Procedures | 2 | 2024 | 223 | 0.720 |
Why?
|
| Genital Diseases, Female | 2 | 2018 | 31 | 0.710 |
Why?
|
| Morcellation | 2 | 2018 | 3 | 0.690 |
Why?
|
| Minimally Invasive Surgical Procedures | 4 | 2015 | 193 | 0.640 |
Why?
|
| Contraception | 3 | 2007 | 61 | 0.630 |
Why?
|
| Uterine Neoplasms | 4 | 2018 | 100 | 0.620 |
Why?
|
| Contraceptive Devices, Female | 2 | 2011 | 2 | 0.610 |
Why?
|
| Gynecology | 3 | 2014 | 128 | 0.580 |
Why?
|
| Leiomyoma | 3 | 2017 | 71 | 0.510 |
Why?
|
| Menstruation Disturbances | 2 | 2003 | 14 | 0.390 |
Why?
|
| Laparoscopy | 4 | 2018 | 540 | 0.360 |
Why?
|
| Nickel | 1 | 2011 | 19 | 0.350 |
Why?
|
| Ovarian Neoplasms | 2 | 2006 | 424 | 0.340 |
Why?
|
| Hysterectomy | 4 | 2018 | 200 | 0.320 |
Why?
|
| Radiography, Interventional | 1 | 2010 | 76 | 0.300 |
Why?
|
| Physicians | 2 | 2015 | 635 | 0.290 |
Why?
|
| Hypersensitivity | 1 | 2011 | 227 | 0.280 |
Why?
|
| Patient Participation | 1 | 2010 | 247 | 0.260 |
Why?
|
| Contraceptive Agents, Female | 1 | 2007 | 31 | 0.250 |
Why?
|
| Sterilization, Reproductive | 2 | 2003 | 5 | 0.250 |
Why?
|
| Dysgerminoma | 1 | 2006 | 4 | 0.250 |
Why?
|
| Luteal Phase | 1 | 2006 | 8 | 0.240 |
Why?
|
| Referral and Consultation | 1 | 2010 | 556 | 0.240 |
Why?
|
| Dermatitis | 1 | 2006 | 27 | 0.240 |
Why?
|
| Sarcoidosis | 1 | 2006 | 51 | 0.240 |
Why?
|
| Glomerulonephritis | 1 | 2006 | 75 | 0.230 |
Why?
|
| Hysterectomy, Vaginal | 2 | 2015 | 19 | 0.220 |
Why?
|
| Progesterone | 1 | 2006 | 440 | 0.210 |
Why?
|
| Autoimmune Diseases | 1 | 2006 | 266 | 0.200 |
Why?
|
| Endometrium | 3 | 2009 | 289 | 0.190 |
Why?
|
| Teratoma | 1 | 2004 | 120 | 0.190 |
Why?
|
| Female | 25 | 2024 | 70388 | 0.190 |
Why?
|
| General Surgery | 1 | 2004 | 225 | 0.180 |
Why?
|
| Fellowships and Scholarships | 1 | 2004 | 323 | 0.170 |
Why?
|
| Menorrhagia | 1 | 2001 | 77 | 0.160 |
Why?
|
| Internship and Residency | 2 | 2014 | 1217 | 0.160 |
Why?
|
| Uterus | 1 | 2004 | 542 | 0.150 |
Why?
|
| Humans | 26 | 2024 | 130483 | 0.150 |
Why?
|
| Contraindications, Procedure | 1 | 2018 | 4 | 0.140 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2018 | 29 | 0.140 |
Why?
|
| Catheter Ablation | 1 | 2001 | 319 | 0.140 |
Why?
|
| Uterine Myomectomy | 1 | 2017 | 13 | 0.130 |
Why?
|
| History, 19th Century | 1 | 2018 | 110 | 0.130 |
Why?
|
| Kidney | 1 | 2004 | 1278 | 0.130 |
Why?
|
| United States Food and Drug Administration | 1 | 2018 | 155 | 0.130 |
Why?
|
| History, 21st Century | 1 | 2018 | 256 | 0.130 |
Why?
|
| Delayed Diagnosis | 1 | 2018 | 129 | 0.120 |
Why?
|
| History, 20th Century | 1 | 2018 | 360 | 0.120 |
Why?
|
| Intellectual Disability | 1 | 2003 | 1080 | 0.120 |
Why?
|
| Hand-Assisted Laparoscopy | 1 | 2015 | 3 | 0.120 |
Why?
|
| Uterine Diseases | 1 | 2015 | 22 | 0.110 |
Why?
|
| Contraceptives, Oral | 2 | 2007 | 38 | 0.110 |
Why?
|
| Private Practice | 1 | 2015 | 21 | 0.110 |
Why?
|
| Sarcoma | 1 | 2017 | 218 | 0.110 |
Why?
|
| Adolescent | 9 | 2009 | 20737 | 0.110 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2015 | 33 | 0.110 |
Why?
|
| Blood Loss, Surgical | 1 | 2015 | 168 | 0.100 |
Why?
|
| Education, Medical, Continuing | 1 | 2015 | 131 | 0.100 |
Why?
|
| Data Collection | 1 | 2015 | 371 | 0.100 |
Why?
|
| Patient Safety | 1 | 2018 | 442 | 0.100 |
Why?
|
| High-Intensity Focused Ultrasound Ablation | 1 | 2012 | 5 | 0.090 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2012 | 7 | 0.090 |
Why?
|
| United States | 3 | 2018 | 11871 | 0.090 |
Why?
|
| Patch Tests | 1 | 2011 | 7 | 0.090 |
Why?
|
| Obstetrics | 1 | 2014 | 240 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2018 | 3679 | 0.090 |
Why?
|
| Administration, Intravaginal | 2 | 2009 | 7 | 0.090 |
Why?
|
| Uterine Artery Embolization | 1 | 2010 | 4 | 0.080 |
Why?
|
| Diagnosis, Differential | 2 | 2006 | 1880 | 0.080 |
Why?
|
| Colposcopy | 1 | 2009 | 17 | 0.080 |
Why?
|
| Misoprostol | 1 | 2009 | 24 | 0.080 |
Why?
|
| Device Removal | 1 | 2011 | 223 | 0.080 |
Why?
|
| Length of Stay | 1 | 2015 | 1395 | 0.080 |
Why?
|
| Oxytocics | 1 | 2009 | 25 | 0.080 |
Why?
|
| Cervix Uteri | 1 | 2009 | 55 | 0.070 |
Why?
|
| Treatment Outcome | 5 | 2018 | 12843 | 0.070 |
Why?
|
| Intrauterine Devices, Medicated | 1 | 2007 | 6 | 0.070 |
Why?
|
| Administration, Cutaneous | 1 | 2007 | 63 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2009 | 3750 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2014 | 1060 | 0.060 |
Why?
|
| Retrospective Studies | 5 | 2018 | 17550 | 0.060 |
Why?
|
| Endometriosis | 1 | 2009 | 163 | 0.060 |
Why?
|
| Patient Satisfaction | 1 | 2010 | 460 | 0.060 |
Why?
|
| Patient Selection | 1 | 2010 | 720 | 0.060 |
Why?
|
| Pelvis | 1 | 2006 | 70 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2007 | 708 | 0.050 |
Why?
|
| Adult | 7 | 2018 | 31179 | 0.050 |
Why?
|
| Radiography | 1 | 2006 | 742 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2006 | 343 | 0.050 |
Why?
|
| Ethics | 1 | 2003 | 22 | 0.050 |
Why?
|
| Reproductive Behavior | 1 | 2003 | 7 | 0.050 |
Why?
|
| Ovary | 1 | 2006 | 353 | 0.050 |
Why?
|
| Vaginal Neoplasms | 1 | 2003 | 17 | 0.050 |
Why?
|
| Neoplasm Staging | 2 | 2004 | 1297 | 0.050 |
Why?
|
| Laparotomy | 1 | 2004 | 138 | 0.050 |
Why?
|
| Endoscopy | 1 | 2004 | 269 | 0.050 |
Why?
|
| Christianity | 1 | 2001 | 15 | 0.040 |
Why?
|
| Religion and Medicine | 1 | 2001 | 26 | 0.040 |
Why?
|
| Syndrome | 1 | 2004 | 1160 | 0.040 |
Why?
|
| Middle Aged | 5 | 2018 | 28438 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2010 | 5081 | 0.040 |
Why?
|
| Texas | 2 | 2012 | 3640 | 0.040 |
Why?
|
| Rhabdomyosarcoma | 1 | 2003 | 228 | 0.040 |
Why?
|
| Sacrum | 1 | 2018 | 28 | 0.040 |
Why?
|
| Suture Techniques | 1 | 2018 | 175 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2006 | 1790 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 2083 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2004 | 4021 | 0.030 |
Why?
|
| Operative Time | 1 | 2015 | 199 | 0.030 |
Why?
|
| Organ Size | 1 | 2015 | 412 | 0.030 |
Why?
|
| Intraoperative Complications | 1 | 2015 | 154 | 0.030 |
Why?
|
| Accreditation | 1 | 2014 | 86 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 2001 | 939 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2001 | 3039 | 0.020 |
Why?
|
| Child | 2 | 2004 | 26101 | 0.020 |
Why?
|
| Maryland | 1 | 2012 | 39 | 0.020 |
Why?
|
| Terbutaline | 1 | 1992 | 7 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2015 | 812 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2001 | 5176 | 0.020 |
Why?
|
| Obstetric Labor, Premature | 1 | 1992 | 76 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2012 | 237 | 0.020 |
Why?
|
| Dysmenorrhea | 1 | 2009 | 13 | 0.020 |
Why?
|
| Students, Medical | 1 | 2014 | 344 | 0.020 |
Why?
|
| Pelvic Pain | 1 | 2009 | 25 | 0.020 |
Why?
|
| Vaginal Smears | 1 | 2009 | 47 | 0.020 |
Why?
|
| Dilatation | 1 | 2009 | 66 | 0.020 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2009 | 33 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2015 | 1679 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2009 | 223 | 0.020 |
Why?
|
| Ribonucleosides | 1 | 1988 | 15 | 0.020 |
Why?
|
| Amantadine | 1 | 1988 | 11 | 0.020 |
Why?
|
| Ribavirin | 1 | 1988 | 86 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 6809 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2009 | 358 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 2298 | 0.020 |
Why?
|
| Pregnancy | 3 | 2014 | 7407 | 0.010 |
Why?
|
| Reoperation | 1 | 2009 | 822 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2009 | 262 | 0.010 |
Why?
|
| Time Factors | 2 | 2012 | 6200 | 0.010 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 1988 | 499 | 0.010 |
Why?
|
| Ameloblastoma | 1 | 1982 | 3 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2015 | 3109 | 0.010 |
Why?
|
| Mandibular Neoplasms | 1 | 1982 | 9 | 0.010 |
Why?
|
| Pneumonia, Viral | 1 | 1988 | 376 | 0.010 |
Why?
|
| Influenza, Human | 1 | 1988 | 701 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2012 | 6450 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 20918 | 0.010 |
Why?
|
| Male | 1 | 2004 | 64488 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1982 | 1534 | 0.010 |
Why?
|
| Infusion Pumps | 1 | 1992 | 31 | 0.010 |
Why?
|
| Parity | 1 | 1992 | 78 | 0.010 |
Why?
|
| Magnesium Sulfate | 1 | 1992 | 52 | 0.010 |
Why?
|
| Gestational Age | 1 | 1992 | 1209 | 0.000 |
Why?
|
| Influenza A virus | 1 | 1988 | 142 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2003 | 14945 | 0.000 |
Why?
|
| Pregnancy Outcome | 1 | 1988 | 615 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1988 | 1168 | 0.000 |
Why?
|
| Hypercalcemia | 1 | 1982 | 41 | 0.000 |
Why?
|
| Prognosis | 1 | 1992 | 4880 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1988 | 8518 | 0.000 |
Why?
|